A trial looking at lenalidomide after chemotherapy for T cell lymphoma of the skin

Cancer type:

Low grade lymphoma
Non-Hodgkin lymphoma




Phase 3

This trial was looking at lenalidomide after treatment with chemotherapy for advanced T cell lymphoma of the skin.

T cell lymphomas of the skin (CTCL) are types of non Hodgkin lymphoma. Mycosis fungoides and Sezary syndrome are the most common types of T cell skin lymphomas, although they are still rare.

Doctors usually treat advanced T cell lymphoma of the skin with chemotherapy drugs called gemcitabine or liposomal doxorubicin. You may also have radiotherapy.

Chemotherapy often shrinks or gets rid of the cancer but sadly it can start to grow again. Doctors are looking for treatments to help people in this situation. In this trial they were testing a drug called lenalidomide.

Lenalidomide is a type of biological therapy. It works mainly by helping the body’s immune system Open a glossary item target cancer cells.

Doctors wanted to find out

  • If having lenalidomide after chemotherapy could prevent or delay the cancer coming back
  • More about the side effects

Summary of results

We have contacted the trial team who tell us that unfortunately they don’t expect to be making results available for this trial.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Sean Whittaker

Supported by

European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 8747

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Over 60,000 cancer patients enrolled on clinical trials in the UK last year.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page